E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/28/2015 in the Prospect News PIPE Daily.

Egalet prices a $75 million public offering of common stock at $11.25

Bookrunners Stifel and Guggenheim Securities to assist with financing

By Devika Patel

Knoxville, Tenn., July 28 – Egalet Corp. said it priced a $75 million public offering of stock with an $11.25 million greenshoe. The offering was announced Monday.

The company will sell 6,666,667 common shares at $11.25 per share. The price per share reflects a 2.34% discount to the July 27 closing share price of $11.52.

Stifel, Nicolaus & Co. Inc. and Guggenheim Securities LLC are the bookrunners.

Settlement is expected July 31.

Proceeds will be used for research and development, commercial sales and marketing efforts and general corporate purposes, including potential business development opportunities.

Wayne, Pa.-based Egalet is a specialty pharmaceutical company focused on developing pain treatments.

Issuer:Egalet Corp.
Issue:Common stock
Amount:$75 million
Greenshoe:$11.25 million, or 1 million shares
Shares:6,666,667
Price:$11.25
Warrants:No
Bookrunners:Stifel, Nicolaus & Co. Inc. and Guggenheim Securities, LLC
Announcement date:July 27
Pricing date:July 28
Settlement date:July 31
Stock symbol:Nasdaq: EGLT
Stock price:$11.52 at close July 27
Market capitalization:$200.26 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.